2023
DOI: 10.3389/fnagi.2023.1120468
|View full text |Cite
|
Sign up to set email alerts
|

The efficacy and safety of asleep and awake subthalamic deep brain stimulation for Parkinson’s disease patients: A 1-year follow-up

Abstract: IntroductionTraditional DBS is usually conducted under local anesthesia (LA) which is intolerable to some patients, DBS under general anesthesia (GA) was opted to extended surgical indication. This study aimed to compare the efficacy and safety of bilateral subthalamic deep brain stimulation (STN-DBS) for Parkinson’s disease (PD) under asleep and awake anesthesia state in 1-year postoperative follow-up.MethodsTwenty-one PD patients were assigned to asleep group and 25 patients to awake group. Patients received… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 43 publications
1
0
0
Order By: Relevance
“…The rate of improved postoperative Med-on status in YOPD patients was significantly higher than at baseline Med-off, suggesting that the combination of DBS and drugs maximized efficacy and significantly reduced postoperative medication doses. Significant progress in overall PDQ-39 scores, consistently with other studies ( Lee et al, 2006 ; Büttner et al, 2019 ; Schuepbach et al, 2019 ; Chen et al, 2023 ). Changes in PDQ-39 were significantly associated with improvements in motor function, further substantiating the effectiveness of STN-DBS and laying the foundation for slowing NMS in YOPD patients.…”
Section: Discussionsupporting
confidence: 88%
“…The rate of improved postoperative Med-on status in YOPD patients was significantly higher than at baseline Med-off, suggesting that the combination of DBS and drugs maximized efficacy and significantly reduced postoperative medication doses. Significant progress in overall PDQ-39 scores, consistently with other studies ( Lee et al, 2006 ; Büttner et al, 2019 ; Schuepbach et al, 2019 ; Chen et al, 2023 ). Changes in PDQ-39 were significantly associated with improvements in motor function, further substantiating the effectiveness of STN-DBS and laying the foundation for slowing NMS in YOPD patients.…”
Section: Discussionsupporting
confidence: 88%